Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Toward a Unified Model of Passive Drug Permeation II: The Physiochemical Determinants of Unbound Tissue Distribution with Applications to the Design of Hepatoselective Glucokinase Activators

Avijit Ghosh, Tristan S. Maurer, John Litchfield, Manthema V. Varma, Charles Rotter, Renato Scialis, Bo Feng, Meihua Tu, Cris R. W. Guimaraes and Dennis O. Scott
Drug Metabolism and Disposition October 2014, 42 (10) 1599-1610; DOI: https://doi.org/10.1124/dmd.114.058032
Avijit Ghosh
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tristan S. Maurer
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Litchfield
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manthema V. Varma
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Rotter
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renato Scialis
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Feng
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meihua Tu
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cris R. W. Guimaraes
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis O. Scott
Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 42 no. 10 1599-1610
DOI 
https://doi.org/10.1124/dmd.114.058032
PubMed 
25024402

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received March 11, 2014
  • Accepted July 14, 2014
  • Published online August 27, 2014.

Article Versions

  • Earlier version (July 14, 2014 - 10:25).
  • Earlier version (July 15, 2014 - 08:55).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Avijit Ghosh,
  2. Tristan S. Maurer,
  3. John Litchfield,
  4. Manthema V. Varma,
  5. Charles Rotter,
  6. Renato Scialis,
  7. Bo Feng,
  8. Meihua Tu,
  9. Cris R. W. Guimaraes, and
  10. Dennis O. Scott
  1. Systems Modeling and Simulation (A.G., T.S.M.), Cardiovascular and Metabolic Disease Research Unit (J.L., D.O.S.), Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Cambridge, Massachusetts; Enzymology and Transporters, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer, Groton, Connecticut (B.F., M.V.V., C.R., R.S.); and World Wide Medicinal Chemistry, Cambridge, Massachusetts (M.T., C.R.W.G.)
  1. Address correspondence to:
    Dr. Avijit Ghosh, Systems Modeling and Simulation, Department of Pharmacokinetics, Pharmacodynamics and Metabolism, Pfizer, 620 Memorial Drive, Cambridge, MA 02139. E-mail: avijit{at}physics.drexel.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2014 to January 2021

AbstractFullPdf
Jul 20144830146
Aug 2014436988
Sep 201497235133
Oct 20142561547
Nov 2014153918
Dec 2014101229
Jan 2015791424
Feb 201529722
Mar 20153026
Apr 201554518
May 2015611021
Jun 2015651119
Jul 201544718
Aug 201547718
Sep 2015271116
Oct 2015481327
Nov 201520913
Dec 2015351411
Jan 2016461227
Feb 2016302528
Mar 2016201520
Apr 2016151520
May 2016151318
Jun 201615924
Jul 201616625
Aug 2016292320
Sep 20161277
Oct 201673722
Nov 2016911123
Dec 201623114
Jan 201733310
Feb 2017512316
Mar 20171919
Apr 201723112
May 201722810
Jun 201713511
Jul 201742216
Aug 201721910
Sep 201743414
Oct 201753315
Nov 201722716
Dec 20171324
Jan 20185289
Feb 20183156
Mar 201812818
Apr 201822913
May 201822411
Jun 201812211
Jul 201822311
Aug 20180247
Sep 20181176
Oct 201832010
Nov 20181189
Dec 201842210
Jan 20198714
Feb 201931910
Mar 2019366
Apr 201981826
May 201943012
Jun 201974817
Jul 201917215
Aug 2019116414
Sep 20193323
Oct 20192638
Nov 2019201010
Dec 201913248
Jan 202081919
Feb 20201295
Mar 20206196
Apr 20200243
May 202022514
Jun 202013214
Jul 202011710
Aug 2020169
Sep 20202056
Oct 20202435
Nov 2020914
Dec 2020904
Jan 20211255

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 42 (10)
Drug Metabolism and Disposition
Vol. 42, Issue 10
1 Oct 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Toward a Unified Model of Passive Drug Permeation II: The Physiochemical Determinants of Unbound Tissue Distribution with Applications to the Design of Hepatoselective Glucokinase Activators
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Toward a Unified Model of Passive Drug Permeation II

Avijit Ghosh, Tristan S. Maurer, John Litchfield, Manthema V. Varma, Charles Rotter, Renato Scialis, Bo Feng, Meihua Tu, Cris R. W. Guimaraes and Dennis O. Scott
Drug Metabolism and Disposition October 1, 2014, 42 (10) 1599-1610; DOI: https://doi.org/10.1124/dmd.114.058032

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Toward a Unified Model of Passive Drug Permeation II

Avijit Ghosh, Tristan S. Maurer, John Litchfield, Manthema V. Varma, Charles Rotter, Renato Scialis, Bo Feng, Meihua Tu, Cris R. W. Guimaraes and Dennis O. Scott
Drug Metabolism and Disposition October 1, 2014, 42 (10) 1599-1610; DOI: https://doi.org/10.1124/dmd.114.058032
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
  • Gene expression profile of human intestinal epithelial cells
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics